CMPI.org

In the News

Qualifying Single-Source Drug Policy, Medicare Price Negotiation, and the Incentives for Meaningful Post-Approval Innovation

10/14/2026 12:00 AM | CMPI

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

08/17/2026 12:00 AM | The Journal of Clinical Investigation

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

08/10/2026 12:00 AM | CMPI

The Empty Price Tag

08/01/2026 12:00 AM | CMPI

We Can Fight Fraud Without Threatening Access to Care

05/08/2026 12:00 AM | RealClearHealth

Big Apple Hospital CEOs are Cooking the Not-for-Profit Hospital Books

03/23/2026 12:00 AM | CMPI

Modernizing North Carolina's Nonprofit Social Contract

03/09/2026 12:00 AM | CMPI

Modernizing Washington’s Nonprofit Social Contract

03/05/2026 12:00 AM | CMPI

Five Hospital Billing Scams That Can Cost You Thousands

02/23/2026 12:00 AM | CMPI

Restoring the Nonprofit Hospital Social Contract

02/17/2026 12:00 AM | CMPI

White Paper: FDA’s Shifting Goalposts—The Human and Economic Cost of Post Hoc Regulatory Rigidity in Biologics (2025–2026)

02/17/2026 12:00 AM | CMPI

Troubling Trends: Hospital Billing, Charity Care, and Consumer Protection in Kansas

02/11/2026 12:00 AM | CMPI

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

02/03/2026 12:00 AM | CMPI

COVID-19 vaccine policy: a response and way forward

02/01/2026 12:00 AM | ScienceDirect

Prescient and Possible: The Excitement and Agita of Living in Interesting Times

10/21/2025 12:00 AM | CMPI

POTUS Can Help American Biotech Compete with China

09/26/2025 12:00 AM | RealClearHealth

Barbarians at the Hospital Gates: Private Equity and its Impact on Patient Care

09/07/2025 12:00 AM | CMPI

Myth or Fact: Mass Compounding

09/05/2025 12:00 AM | CMPI

Troubling Trends in Pennsylvania"s Non-Profit Hospitals

08/27/2025 12:00 AM | CMPI

Troubling Trends in Connecticut’s Non-Proﬁt Hospitals

08/19/2025 12:00 AM | CMPI

1
2
3
4
...
12
Next

RECENT NEWS

Qualifying Single-Source Drug Policy, Medicare Price Negotiation, and the Incentives for Meaningful Post-Approval Innovation

CMPI
10/14/2026 12:00 AM

Qualifying Single-Source Drug Policy, Medicare Price Negotiation, and the Incentives for Meaningful Post-Approval Innovation

CMS should demand evidence from manufacturers and be prepared to defend its own assumptions about innovation. Its next st... Read more

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

The Journal of Clinical Investigation
08/17/2026 12:00 AM

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients... Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

CMPI
08/10/2026 12:00 AM

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis... Read more

Read all News